10-68989034-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_015634.4(KIFBP):āc.202G>Cā(p.Gly68Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,613,618 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_015634.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIFBP | NM_015634.4 | c.202G>C | p.Gly68Arg | missense_variant | 1/7 | ENST00000361983.7 | NP_056449.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152262Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000546 AC: 135AN: 247050Hom.: 1 AF XY: 0.000529 AC XY: 71AN XY: 134264
GnomAD4 exome AF: 0.000131 AC: 191AN: 1461238Hom.: 0 Cov.: 33 AF XY: 0.000127 AC XY: 92AN XY: 726914
GnomAD4 genome AF: 0.000171 AC: 26AN: 152380Hom.: 1 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74512
ClinVar
Submissions by phenotype
Goldberg-Shprintzen syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 10, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at